Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Liabilities (2020 - 2025)

Biofrontera (BFRI) has 6 years of Total Liabilities data on record, last reported at $18.0 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 38.58% year-over-year to $18.0 million; the TTM value through Sep 2025 reached $18.0 million, up 38.58%, while the annual FY2024 figure was $17.7 million, 23.64% down from the prior year.
  • Total Liabilities reached $18.0 million in Q3 2025 per BFRI's latest filing, down from $24.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $41.9 million in Q4 2021 and bottomed at -$7.2 million in Q2 2023.
  • Average Total Liabilities over 5 years is $21.2 million, with a median of $24.8 million recorded in 2025.
  • Peak YoY movement for Total Liabilities: skyrocketed 2560.31% in 2022, then tumbled 119.71% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $41.9 million in 2021, then crashed by 35.52% to $27.0 million in 2022, then decreased by 14.32% to $23.1 million in 2023, then fell by 23.64% to $17.7 million in 2024, then increased by 1.86% to $18.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $18.0 million in Q3 2025, $24.8 million in Q2 2025, and $16.1 million in Q1 2025.